Dr. Rakhee Vaidya
Claim this profileWake Forest University Health Sciences
Area of expertise
Lymphoma
Rakhee Vaidya has run 8 trials for Lymphoma. Some of their research focus areas include:
Non-Hodgkin's Lymphoma
Rakhee Vaidya has run 4 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Wake Forest University Health Sciences
Wake Forest Baptist Health
Clinical Trials Rakhee Vaidya is currently running
Immunotherapy
for Hodgkin's Lymphoma
This trial is testing a new treatment called mosunetuzumab against the usual treatment, rituximab, for patients with a type of cancer called NLPHL. Both treatments help the immune system find and kill cancer cells by targeting a specific protein on these cells. The goal is to see if mosunetuzumab can improve survival better than rituximab.
Recruiting
1 award
Phase 2
Rituximab vs Mosunetuzumab
for Follicular Lymphoma
This phase III trial compares the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden. Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. It is not yet known if giving rituximab or mosunetuzumab works better in treating patients with follicular lymphoma with a low tumor burden.
Recruiting
2 awards
Phase 3
13 criteria
More about Rakhee Vaidya
Clinical Trial Related
8 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Rakhee Vaidya has experience with
- Mosunetuzumab
- Rituximab
- Autologous Hematopoietic Stem Cell Transplantation
- Polatuzumab Vedotin
- ASTX660
- CPI-613
Breakdown of trials Rakhee Vaidya has run
Lymphoma
Non-Hodgkin's Lymphoma
Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rakhee Vaidya specialize in?
Rakhee Vaidya focuses on Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved CD30 positive patients, or patients who are Stage IV.
Is Rakhee Vaidya currently recruiting for clinical trials?
Yes, Rakhee Vaidya is currently recruiting for 4 clinical trials in Winston-Salem North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Rakhee Vaidya has studied deeply?
Yes, Rakhee Vaidya has studied treatments such as Mosunetuzumab, Rituximab, Autologous Hematopoietic Stem Cell Transplantation.
What is the best way to schedule an appointment with Rakhee Vaidya?
Apply for one of the trials that Rakhee Vaidya is conducting.
What is the office address of Rakhee Vaidya?
The office of Rakhee Vaidya is located at: Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157 United States. This is the address for their practice at the Wake Forest University Health Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.